- Home
- CLGN vs BEDU Comparison
CLGN vs BEDU Comparison
Compare CLGN & BEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- BEDU
- Stock Information
- Founded
- CLGN 2004
- BEDU 1994
- Country
- CLGN Israel
- BEDU United Kingdom
- Employees
- CLGN N/A
- BEDU N/A
- Industry
- CLGN Industrial Specialties
- BEDU Other Consumer Services
- Sector
- CLGN Health Care
- BEDU Real Estate
- Exchange
- CLGN Nasdaq
- BEDU Nasdaq
- Market Cap
- CLGN 37.4M
- BEDU 47.7M
- IPO Year
- CLGN N/A
- BEDU 2017
- Fundamental
- Price
- CLGN $1.82
- BEDU $1.51
- Analyst Decision
- CLGN Strong Buy
- BEDU
- Analyst Count
- CLGN 2
- BEDU 0
- Target Price
- CLGN $12.50
- BEDU N/A
- AVG Volume (30 Days)
- CLGN 12.7K
- BEDU 13.6K
- Earning Date
- CLGN 05-28-2025
- BEDU 04-28-2025
- Dividend Yield
- CLGN N/A
- BEDU N/A
- EPS Growth
- CLGN N/A
- BEDU N/A
- EPS
- CLGN N/A
- BEDU N/A
- Revenue
- CLGN $515,000.00
- BEDU $224,321,752.00
- Revenue This Year
- CLGN $2,177.67
- BEDU N/A
- Revenue Next Year
- CLGN $56.52
- BEDU N/A
- P/E Ratio
- CLGN N/A
- BEDU N/A
- Revenue Growth
- CLGN N/A
- BEDU N/A
- 52 Week Low
- CLGN $1.82
- BEDU $1.35
- 52 Week High
- CLGN $6.75
- BEDU $2.42
- Technical
- Relative Strength Index (RSI)
- CLGN 23.18
- BEDU 42.49
- Support Level
- CLGN $2.00
- BEDU $1.40
- Resistance Level
- CLGN $2.40
- BEDU $1.94
- Average True Range (ATR)
- CLGN 0.21
- BEDU 0.11
- MACD
- CLGN -0.01
- BEDU -0.00
- Stochastic Oscillator
- CLGN 3.59
- BEDU 20.41
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom (the UK) and the United States (the U.S.) Kingdom. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.